International Psoriasis Council

Advancing Knowledge. Improving Care.

Filip

Rob

,

MD, PhD

Charles University
Prague
,
Czech Republic
2018 Fellow
Councilor Since: September 8, 2022
IPC Councilor
Dr. Rob is the head of the Dermatovenereology Department at the Second Faculty of Medicine, Charles University, University Hospital Bulovka, Prague, Czech Republic. Dr. Rob is published as the lead author on 20 manuscripts dealing with psoriasis and is leading research related to HPV and psoriasis as well as skin and gut microbiota changes in psoriasis patients on biologics.

As a 2018 Fellow, he studied with Dr. Joel Gelfand, MD, MSCE, at the University of Pennsylvania and attended the 27th European Academy of Dermatology and Venereology (EADV) Congress in Paris. While in Philadelphia, he shadowed Prof. Gelfand in his outpatient clinic for patients with psoriasis and attended his research team meetings and other events organized by the department. He was exposed to research cardiovascular comorbidities in psoriasis and their management, advanced phototherapy, and pragmatic clinical trials in psoriasis.
Last Updated:
07/27/2022

IPC Committees / Groups

Disease Severity Working Group

What's New

First-Line Biologics in Psoriasis: Evidence from the BADBIR Cohort Study

In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.

Read More »

Recent Advances in Psoriasis: A Year in Review

In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.

WATCH NOW

Monday, April 6, 2026